U
SGAR

UBS’s iPath Pure Beta Sugar ETN SGAR Stock Holding History

UBS’s Portfolio SGAR Stock Details SGAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$39K Buy
1,314
+339
+35% +$10.9K ﹤0.01% 7149
2014
Q2 		$35K Buy
975
+220
+29% +$8K ﹤0.01% 7372
2014
Q1 		$28K Buy
755
+503
+200% +$17.8K ﹤0.01% 7662
2013
Q4 		$9K Buy
+252
New +$9.25K ﹤0.01% 9134
2013
Q3 		– Sell
-146
Closed -$5K – 10918
2013
Q2 		$5K Buy
+146
New +$5.47K ﹤0.01% 9308

UBS's SGAR Position: Q3 2014 in Review

UBS increased its iPath Pure Beta Sugar ETN (SGAR) stake by 35% in Q3 2014, buying an estimated $10.9K and bringing the position to 1,314 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #7149.

UBS first reported a position in SGAR in Q2 2013 and has held it in 5 quarters since. 2 funds tracked by Wall St. Rank hold SGAR as of Q3 2014.

  • UBS held 1,314 shares of iPath Pure Beta Sugar ETN worth $39K as of Q3 2014.
  • UBS bought 339 iPath Pure Beta Sugar ETN shares in Q3 2014, an estimated $10.9K.
  • iPath Pure Beta Sugar ETN made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7149 holding.
  • UBS first reported a position in iPath Pure Beta Sugar ETN in Q2 2013 and has held it in 5 quarters since.
  • 2 funds tracked by Wall St. Rank held iPath Pure Beta Sugar ETN as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.